FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable or Metastatic Cholangiocarcinoma By Ogkologos - May 20, 2026 135 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for safety and efficacy is based on the findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Mark Hoppus Of Blink-182 Announces He’s Cancer-Free October 8, 2021 Cancer in My Community: Continuing to Improve Australia’s Strong Cancer Survival... December 8, 2020 How Some Brain Tumors Hijack the Mind to Grow June 21, 2023 Adding Lenvatinib to Pembrolizumab Does Not Provide Additional Benefit in Patients... September 10, 2025 Load more HOT NEWS Withdrawal of the Application to Change the EMA Marketing Authorisation for... Research Says That Your Birth Order Can Shape Your Personality Pink Van Makes the Rounds Throughout Rural New Zealand to Offer... Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously...
